Sweet's syndrome during induction chem... - Sweet's Syndrome UK

Sweet's Syndrome UK

488 members298 posts

Sweet's syndrome during induction chemotherapy for acute myeloid leukemia – case report and mini review.

Shell567 profile image
Shell567AdministratorSweet's Syndrome UK
0 Replies

In 15-20% of cases, Sweet's syndrome (SS) develops secondary to cancer, the blood cancer, acute myeloid leukaemia (AML), being the commonest. Out of the total number of malignancy-associated cases, 85% have blood cancer.

This is a case of a 47-year-old woman who developed skin lesions that appeared on the third day after initiation of induction chemotherapy for AML. Skin biopsy suggested SS that was successfully treated with oral steroid medication.

- Induction chemotherapy with cytarabine and daunorubicin.

- Initially, non-itchy skin lesion on left forearm. Later, lesions developed on the neck and venipuncture sites (site of a vein where blood is taken). The latter was pathergy - skin lesions develop where the skin has been damaged. Lesions then became itchy and appeared on back.

- Fever of 39°C.

- Low white blood cell count, including neutrophil count. Normally high in SS, but more likely to be normal or low in patients with cancer/having chemotherapy.

- Elevated C-reactive protein indicating increased levels of inflammation in the body.

- SS can be drug-induced. Allopurinol, dipyrone, sulfamethoxazole and trimethoprim, cefepime, clindamycin and fluconazole were the main drugs used prior to the appearance of skin lesions. There seemed to be no connection between the appearance of the skin lesions and any of these drugs given during hospitalization.

- "The deletion of chromosome 5 or 5q and the presence of FLT3 mutations were the cytogenetic and molecular changes associated with a higher occurrence of SS (Kazmi et al, 2015)." However, "in a series of 13 Egyptian patients with AML and SS, cytogenetic alterations were documented in nine cases (El-Khalawany et al, 2017). None of these cytogenetic alterations found was more prevalent or associated with a higher occurrence of SS."

Spacek da Fonseca, G., Flávia Dinardi Alves Pinto, A., Cristina Fernandes Silveira, S., Henrique do Amaral e Silva, J., Afonso da Silva, V. and Rodrigues de Oliveira, L. (2020) Sweet's syndrome during induction chemotherapy for acute myeloid leukemia – case report and mini review. Hematology, Transfusion and Cell Therapy, Jul 20 (ScienceDirect). sciencedirect.com/science/a...

Written by
Shell567 profile image
Shell567
Administrator
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

An Introduction to Sweet's syndrome - links to information (pinned post)

Sweet’s syndrome is an autoinflammatory (not autoimmune) condition and form of neutrophilic...
Shell567 profile image
Administrator

Does anyone have problems with pathergy?

Pathergy is when lesions can develop in an area where the skin is damaged or irritated. It affects...
Shell567 profile image
Administrator

Coronavirus - COVID 19

SS patients may find it harder to recover from COVID 19, and there could be an increased risk of...
Shell567 profile image
Administrator

Moderation team

Shell567 profile image
Shell567Administrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.